• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
RHY
Click for more information
0.00% 8.2¢

RHYTHM BIOSCIENCES LIMITED - News & Media

Market Cap $20.17M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare

Rhythm Biosciences Limited is an Australia-based medical diagnostics company. The Company... Rhythm Biosciences Limited is an Australia-based medical diagnostics company. The Company is engaged in the development and commercialization of Australian medical diagnostics technology for sale in domestic and international markets. The Company’s ColoSTAT a blood-base cancer test, designed for the early detection of colorectal cancer, has been developed initially as an alternative screening test for individuals unable to or unwilling to use available screening modalities. ColoSTAT is indicated to screen adults, aged 40 to 85, at average risk for developing Colorectal Cancer (CRC). The test-kit measures five specific biomarkers in the blood that either increase or decrease in quantity when CRC tumors are present.More

Articles & Videos

Rhythm Biosciences flags positive data for lung cancer diagnostic test

Rhythm Biosciences (ASX:RHY) has received positive preliminary data from the Baker Institute, in regard to its lung cancer diagnostic test.

24 Nov 2023 12:34 (AEDT)

Rhythm BioSciences (ASX: RHY) pens partnership with LINK Medical Solutions

Rhythm BioSciences (ASX:RHY) has announced it is progressing with its entry of ColoSTAT into the United Kingdom.

24 May 2023 10:02 (AEST)

Rhythm Biosciences (ASX:RHY) share price doubles over UK approval for ColoSTAT

Rhythm Biosciences (ASX:RHY) has gained regulatory approval for its colon cancer detection blood test in the United Kingdom.

17 May 2023 13:48 (AEST)

Rhythm Biosciences (ASX:RHY) withdraws TGA application for ColoSTAT

Cancer diagnostics technology company Rhythm Biosciences (ASX:RHY) has withdrawn its application for an Australian Register of Therapeutic Goods (ARTG) listing for its ColoSTAT technology.

06 Mar 2023 14:01 (AEDT)

Rhythm Biosciences (ASX:RHY) retains fifth consecutive ISO certification for ColoSTAT

Rhythm Biosciences (RHY) has retained its ISO certification for its ColoSTAT test for a fifth consecutive year.

15 Feb 2023 16:07 (AEDT)



(20min delay)
Last
8.2¢ 		Change
0.000(0.00%) 		Mkt cap ! $20.17M
Open High Low Value Volume
8.4¢ 8.4¢ 8.2¢ $3.672K 44.19K

Buyers (Bids)

No. Vol. Price($)
1 140 8.2¢
 

Sellers (Offers)

Price($) Vol. No.
8.3¢ 16814 2
View Market Depth
Last trade - 14.13pm 06/05/2024 (20 minute delay) ?
Last
8.2¢ 		  Change
0.000 ( 0.00 %)
Open High Low Volume
8.2¢ 8.2¢ 8.2¢ 514
Last updated 12.02pm 06/05/2024 ?
RHY (ASX) Chart

Top Stories

Maiden drilling at West Arunta hints at major IOCG system for Rincon

Rincon Resources believes that drill core picked up from a maiden program of work at its West Arunta project in Western Australia indicates potential for a major iron oxide copper gold deposit.
Westpac tracks lower in profits in first half of 2024, with a 16% yoy drop amid slowing economy Westpac Banking Corporation has reported a 16 percent drop in net profit (to $3.342 billion) for the first half of the 2024 financial year compared to the same time last year.
Tamboran is listing on the NYSE, and Wall Street is paying attention If you needed evidence that Tamboran Resources is bullish on the NT's Beetaloo Basin, look no further than its decision to list on the NYSE.
Mantle Minerals to kick off drilling at Mt Berghaus in WA Mantle Minerals (ASX:MTL) has announced it's kicking off a 122-hole drill run on-site its Mt Berghaus acreage in Western Australia.
Sold out signs go up for RIU Resources Roundup in Sydney More than 115 companies will be participating in this year's RIU Resources Roundup in Sydney.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.